Editorial Committee and Version Control
The Clinical Management Guidelines are edited on an ongoing basis and in accordance with the Drug Therapy Protocol - Sexual Health Program Nurses (including Reproductive Health) requirements by the Clinical Guidelines Editorial Committee. This means that sections of the guidelines are updated at different times to reflect emerging issues, contemporary evidence and principles of best practice.
For more information on the Committee, their Terms of Reference and meeting outcomes go to the Clinical Guidelines Editorial Committee page.
Sexual Health Program Nurse Authorisation
For updated information on changes to the authorisation processes for sexual health nurse authorisations, please visit the Queensland Health Medicines and Poisons webpage.
Feedback
To provide feedback to the Editorial Committee on any aspect of the Guidelines, including recommendations on additional topics, expanded content, content requiring update or amendment to comply with an agreed standard, or general feedback, please complete the following template.
Table of contents
The document has been split into section for quick downloading. Please note the listed version control dates.
Section 1 - History and assessment (2010)
Legal obligations
Informed consent
Comprehensive sexual health assessment
History taking
Risk assessment
Examination
Investigations
Follow-up
Education
Contact tracing
Asymptomatic screen
Management and treatment
Reference list
top
of page
Section 2 - Screening priority groups (2010)
Cultural and Linguistically Diverse (CALD) populations
Indigenous populations
Men who have sex with men (MSM)
People who inject drugs (PWID)
Sex industry workers (SIW)
Young people
Reference list
top
of page
Section 3 - Syndromic Presentations (2010)
top
of page
Section 4 - Treatment and Management (updated August 2012)
Anaphylaxis
Atrophic vaginitis
Bacterial vaginosis (BV)
Balanitis and Balanoposthitis
Candidiasis
Cervicitis
Chancroid
Chlamydia
Donovanosis
Dyspareunia
Epididymo-orchitis
Genital Herpes (HSV)
Genital Warts - human papilloma virus (HPV)
Gonorrhoea
HIV and AIDS
Lymphogranuloma Venereum (LGV)
Molluscum contagiosum
Non Gonococcal Urethritis (NGU)
Pelvic Inflammatory Disease (PID)
Proctitis
Pubic lice
Scabies
Syphilis
Tinea Cruris
Trichomonias
Urinary Tract Infection (UTI)
Vaccination - Hepatitis A (HAV)
Vaccination - Hepatitis B (HBV)
Vaccination - HPV
Reference list
top
of page
Section 5 - Reproductive Health (2010)
Protocols for hormonal contraception
Evidence base for this section
Applying medical eligibility criteria
Levonorgestrel Emergency Contraception (LNG EC)
Combined Oral Contraception (COC)
Progestogen - Only Pill (POP)
Combined Hormonal Vaginal Ring : Nuva Ring ®
Administration of Depot Medroxyprogesterone Acetate (DMPA)
Barrier methods
Pregnancy
Reference list
top
of page
Section 6 – Emergency presentations (2010)
top
of page
Section 7 - Procedures
Examination - general
Examination - breast awareness and clinical breast examination
Examination - bimanual / pelvic
Examination - proctoscopy and rectal swab
Examination - speculum
Examination / instruction - testicles
First catch urine
Gram stain
Immunisation
Mid-stream urine
Pre- and post-test information
Phone information
Press slide donovanosis
Swab - cervical
Swab -GUMP
Swab - HSV PCR
Swab - urethral
Swab - throat
Swab - vaginal
Self-collected low vaginal swab
Self-collected anal swab
Venepuncture
Wart treatment
Wet preparation
Reference list
Section 8 - Nursing Officer Information (updated August 2012)
Definition of a sexual and reproductive health program
Definition of nursing roles
Scope of practice
Clinical consultation protocols
Competence
Supporting documents:
Drug Therapy Protocol Sexual and Reproductive Health Program, and
Queensland Competency Standards for the advanced Sexual and reproductive health nursing officer - June 2007, and
Queensland Sexual and Reproductive Health: Performance appraisal and development agreement (2007).
Anaphylaxis competency
Reference list
Drug Therapy Protocol: Sexual and reproductive health program
Section 9 - Appendices
Appendix 1. Drugs in pregnancy
Appendix 2. Reporting adverse drug events
Appendix 3. Acronyms
Appendix 4. Sexual Health Contacts
Appendix 5. Ordering the SHFPA contraceptive handbook
Appendix 6. Notification of STI
Appendix 7. Use of returned or unused dispensed medicines
Appendix 8. Preferred pathology specimens table
top
of page
Indicates mandatory field
